中山醫學大學機構典藏 CSMUIR:Item 310902500/24467
English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 17901/22917 (78%)
造訪人次 : 7657643      線上人數 : 256
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧：
  • 您可在西文檢索詞彙前後加上"雙引號"，以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋，建議至進階搜尋限定作者欄位，可獲得較完整資料
    •  進階搜尋


    請使用永久網址來引用或連結此文件: https://ir.csmu.edu.tw:8080/ir/handle/310902500/24467


    題名: The risks of ubiquinone and beta-carotene deficiency and metabolic disorders in patients with oral cancer
    作者: Chan, MY;Lee, BJ;Chang, PS;Hsiao, HY;Hsu, LP;Chang, CH;Lin, PT
    關鍵詞: Ubiquinone;beta-Carotene;Antioxidant vitamins;Metabolic disorders;Oral cancer
    日期: 2020
    上傳時間: 2022-08-09T08:02:48Z (UTC)
    出版者: BMC
    摘要: BackgroundCancer development is mediated by oxidative stress and inflammation, which may correlate with metabolic disorders. The aim of this study was to evaluate antioxidant vitamins status and metabolic parameters in patients with oral cancer according to tumor-node-metastasis (TNM) stages.MethodsA total of 194 patients with oral cancer were enrolled in this study. The patients were stratified for four groups according to cancer stages and that the statistics are comparisons across these groups. The levels of antioxidant vitamins (ubiquinone, beta -carotene, vitamin A and E), metabolic parameters, oxidative stress, antioxidant enzymes activity, and inflammatory markers were measured.ResultsMore than half of the subjects had high blood pressure, central obesity, hyperglycemia, and hyperlipidemia regardless of TNM stage. With regard to antioxidant vitamins status, 46 and 94% of patients had beta -carotene and ubiquinone deficiency, respectively. Patients in T3 and T4 stages had significantly lower antioxidant enzyme (catalase, p=0.03) activity and higher inflammatory markers levels (high sensitivity C-reactive protein and interleukin-6, p<0.01) than patients in the other stages. In addition, the level of <beta>-carotene was negatively associated with waist circumference, and ubiquinone was positively associated with the level of high-density lipoprotein cholesterol (p<0.05). Higher <beta>-carotene and ubiquinone levels were negatively associated with hypertriglyceridemia and the risk of metabolic syndrome (p<0.05).ConclusionsA high proportion of patients with oral cancer had ubiquinone or <beta>-carotene deficiency and metabolic disorders. The level of ubiquinone or beta -carotene was negatively associated with the risk of central obesity, hypertriglyceridemia, and metabolic syndrome. Since patients with oral cancer suffer from high oxidative stress and inflammation (particularly in the T3 and T4 stages), supplementation with antioxidant vitamins such as ubiquinone or beta -carotene could be preferentially applied.
    URI: http://dx.doi.org/10.1186/s12885-020-06839-9
    https://www.webofscience.com/wos/woscc/full-record/WOS:000531187700009
    https://ir.csmu.edu.tw:8080/handle/310902500/24467
    關聯: BMC CANCER ,2020 ,v20 ,issue 1
    顯示於類別:[中山醫學大學研究成果] 期刊論文

    文件中的檔案:

    檔案 描述 大小格式瀏覽次數
    index.html0KbHTML201檢視/開啟


    SFX Query

    在CSMUIR中所有的資料項目都受到原著作權保護.

    TAIR相關文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋